After Crinetics' $10 Billion Deal, Could Entera Bio Be the Next Category-Defining Oral Peptide Story?

WSW, NY, July 15th, 2026, FinanceWireOn July 6, 2026, Vertex Pharmaceuticals (NASDAQ: VRTX) agreed to acquire Crinetics ...